Skip to main content
    J

    Jasper Therapeutics Inc (JSPR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $11.77
    -1.91 (-13.96%)

    Market Cap: $15.18M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Jasper Therapeutics Inc (JSPR) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Jasper Therapeutics are Marker Therapeutics (MRKR), Pluri (PLUR) and Estrella Immunopharma (ESLA). By market cap, Jasper Therapeutics ranks 8th of the 13 companies on this page; Plus Therapeutics (PSTV) is the largest at $26.64M.

    Peer Comparison

    JSPR's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Jasper Therapeutics (JSPR)$15.18MN/A1.6x0.0%N/A0.0%0.00%
    Marker Therapeutics Inc (MRKR)$14.51MN/A14.5x-245.5%N/A-51.0%0.00%
    Pluri Inc. (PLUR)$15.09MN/A8.7x0.0%-650.8%-15.8%0.00%
    Estrella Immunopharma Inc. (ESLA)$22.36MN/AN/A0.0%N/A0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Tscan Therapeutics Inc (TCRX)$10.89MN/A3.6x0.0%-129.7%-65.8%0.00%
    Akari Therapeutics PLC (AKTX)$15.54MN/AN/A0.0%N/A0.0%0.00%
    Context Therapeutics Inc (CNTX)$16.61MN/AN/A0.0%N/A0.0%0.00%
    CEL-SCI Corp (CVM)$22.51MN/AN/A0.0%-109.0%-62.7%0.00%
    Seres Therapeutics Inc (MCRB)$14.27MN/A6.6x0.0%N/A68.9%0.00%
    Tvardi Therapeutics, Inc. (TVRD)$15.74MN/AN/A0.0%N/A0.0%0.00%
    Quoin Pharmaceuticals Ltd DRC (QNRX)$17.78MN/AN/A0.0%N/A0.0%0.00%
    Passage Bio Inc (PASG)$13.68MN/AN/A0.0%N/A0.0%0.00%
    Peer median$15.64MN/A6.6x0.0%-390.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Jasper Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Marker Therapeutics Inc (MRKR)
    Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based...
    MRKR competitors
    Pluri Inc. (PLUR)
    Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy...
    PLUR competitors
    Estrella Immunopharma Inc. (ESLA)
    Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
    ESLA competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Tscan Therapeutics Inc (TCRX)
    Tscan Therapeutics Inc (TCRX) is a pioneering clinical-stage biotechnology company specializing in precision oncology through its proprietary T cell receptor...
    TCRX competitors
    Akari Therapeutics PLC (AKTX)
    Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory...
    AKTX competitors
    Context Therapeutics Inc (CNTX)
    Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid...
    CNTX competitors
    CEL-SCI Corp (CVM)
    CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases.
    CVM competitors
    Seres Therapeutics Inc (MCRB)
    Seres Therapeutics, Inc., a microbiome therapeutic platform company, is involved in the development of bacterial consortia that are designed to functionally...
    MCRB competitors
    Tvardi Therapeutics, Inc. (TVRD)
    Tvardi Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing novel oncology therapies to meet critical unmet...
    TVRD competitors
    Quoin Pharmaceuticals Ltd DRC (QNRX)
    Quoin Pharmaceuticals Ltd (QNRX) is an innovative biotechnology firm dedicated to developing cutting-edge therapeutics for rare diseases...
    QNRX competitors
    Passage Bio Inc (PASG)
    Passage Bio, Inc., a genetic drug company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases.
    PASG competitors

    Frequently Asked Questions About JSPR

    Who are Jasper Therapeutics' main competitors?

    The companies most similar to Jasper Therapeutics include Marker Therapeutics (MRKR), Pluri (PLUR), Estrella Immunopharma (ESLA), Plus Therapeutics (PSTV) and Tscan Therapeutics (TCRX), listed from the closest match.

    Who is Jasper Therapeutics' biggest competitor?

    Plus Therapeutics (PSTV) is the largest of the similar companies at $26.64M; Marker Therapeutics (MRKR) is the closest match by business profile, size, sector and industry.

    How does JSPR stock compare with its competitors?

    JSPR's P/S is 1.6x against a peer median of 6.6x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Jasper Therapeutics' competitors pays a higher dividend?

    Jasper Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Jasper Therapeutics bigger than its competitors?

    No. Jasper Therapeutics is 8th by market cap among the 13 companies on this page; the largest is Plus Therapeutics (PSTV) at $26.64M.